Table 1 Sample characteristics... | American Society of Hematology

Table 1

Sample characteristics

Characteristic	Total sample (N = 1786)	Non-CVD sample (n = 1595)
Age, y	66 ± 9	66 ± 9
Female, %	54	56
Systolic blood pressure, mmHg	128 ± 17	128 ± 17
Diastolic blood pressure, mmHg	74 ± 10	74 ± 10
Body mass index, kg/m²	28 ± 5	28 ± 5
Fasting glucose, mg/dL	107 ± 24	106 ± 23
Total cholesterol, mg/dL	186 ± 38	189 ± 36
LDL cholesterol, mg/dL	105 ± 31	107 ± 31
HDL cholesterol, mg/dL	57 ± 18	58 ± 18
Triglycerides, mg/dL	118 ± 71	116 ± 69
Hypertension, %	63	59
Diabetes mellitus, %	14	12
Cigarette smoking, %	8	8
Medications, %
ACE inhibitors	25	22
Angiotensin receptor blockers	8	7
Beta-blockers	27	22
Calcium channel blockers	14	12
Diuretics	23	21
Hormone replacement	4	5
Statins	41	37
Framingham risk score	9 ± 4	8 ± 4
Prevalent cardiovascular disease, %	11

Characteristic	Total sample (N = 1786)	Non-CVD sample (n = 1595)
Age, y	66 ± 9	66 ± 9
Female, %	54	56
Systolic blood pressure, mmHg	128 ± 17	128 ± 17
Diastolic blood pressure, mmHg	74 ± 10	74 ± 10
Body mass index, kg/m²	28 ± 5	28 ± 5
Fasting glucose, mg/dL	107 ± 24	106 ± 23
Total cholesterol, mg/dL	186 ± 38	189 ± 36
LDL cholesterol, mg/dL	105 ± 31	107 ± 31
HDL cholesterol, mg/dL	57 ± 18	58 ± 18
Triglycerides, mg/dL	118 ± 71	116 ± 69
Hypertension, %	63	59
Diabetes mellitus, %	14	12
Cigarette smoking, %	8	8
Medications, %
ACE inhibitors	25	22
Angiotensin receptor blockers	8	7
Beta-blockers	27	22
Calcium channel blockers	14	12
Diuretics	23	21
Hormone replacement	4	5
Statins	41	37
Framingham risk score	9 ± 4	8 ± 4
Prevalent cardiovascular disease, %	11

Values shown are means ± SD or percentages.